- A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1
-
De U, Kundu S, Patra N, Ahn MY, Ahn JH, Son JY, Yoon JH, Moon HR, Lee BM, Kim HS
- KMID: 2380292
- Biomol Ther.
- 2015 Sep;23(5):434-441.
- doi: 10.4062/biomolther.2015.026
Histone deacetylase (HDAC) inhibitors are considered novel agents for cancer chemotherapy. We previously investigated MHY219, a new HDAC inhibitor, and its potent anticancer activity in human prostate cancer cells. In... -
- CITED
-
- Close
- SHARE
-
- Close
